Jane Street’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Sell
115,863
-139,261
-55% -$141M 0.01% 613
2025
Q4
$274M Sell
255,124
-141,948
-36% -$136M 0.04% 277
2025
Q3
$303M Buy
397,072
+332,245
+513% +$247M 0.05% 265
2025
Q2
$50.5M Buy
64,827
+56,867
+714% +$44.2M 0.01% 755
2025
Q1
$6.57M Sell
7,960
-531,743
-99% -$442M ﹤0.01% 2513
2024
Q4
$417M Sell
539,703
-10,869
-2% -$9M 0.09% 126
2024
Q3
$488M Buy
550,572
+92,311
+20% +$83M 0.11% 101
2024
Q2
$415M Buy
458,261
+246,492
+116% +$197M 0.09% 102
2024
Q1
$165M Sell
211,769
-333,906
-61% -$238M 0.03% 260
2023
Q4
$318M Buy
545,675
+416,712
+323% +$243M 0.08% 128
2023
Q3
$69.3M Sell
128,963
-82,639
-39% -$42.6M 0.02% 436
2023
Q2
$99.2M Sell
211,602
-689,406
-77% -$289M 0.03% 340
2023
Q1
$309M Buy
901,008
+842,061
+1,429% +$284M 0.13% 84
2022
Q4
$21.6M Sell
58,947
-41,584
-41% -$14.7M 0.01% 955
2022
Q3
$32.5M Buy
100,531
+5,737
+6% +$1.82M 0.01% 738
2022
Q2
$30.7M Buy
94,794
+13,980
+17% +$4.2M 0.01% 813
2022
Q1
$23.1M Buy
80,814
+32,137
+66% +$8.27M 0.01% 1143
2021
Q4
$13.4M Sell
48,677
-16,232
-25% -$4.11M ﹤0.01% 1549
2021
Q3
$15M Sell
64,909
-148,648
-70% -$36.7M 0.01% 1349
2021
Q2
$49M Sell
213,557
-26,277
-11% -$5.28M 0.02% 561
2021
Q1
$44.8M Buy
239,834
+94,349
+65% +$18.5M 0.02% 533
2020
Q4
$24.6M Sell
145,485
-6,368
-4% -$951K 0.01% 750
2020
Q3
$22.5M Buy
151,853
+4,193
+3% +$649K 0.01% 715
2020
Q2
$24.2M Buy
147,660
+128,324
+664% +$19.7M 0.02% 656
2020
Q1
$2.68M Buy
19,336
+10,486
+118% +$1.44M ﹤0.01% 1722
2019
Q4
$1.16M Sell
8,850
-23,144
-72% -$2.68M ﹤0.01% 2570
2019
Q3
$3.58M Buy
31,994
+14,709
+85% +$1.64M 0.01% 1251
2019
Q2
$1.92M Sell
17,285
-77,593
-82% -$9.14M ﹤0.01% 1918
2019
Q1
$12.3M Buy
94,878
+64,157
+209% +$7.8M 0.02% 586
2018
Q4
$3.56M Sell
30,721
-28,040
-48% -$3.13M 0.01% 1178
2018
Q3
$6.31M Buy
58,761
+30,032
+105% +$3M 0.01% 882
2018
Q2
$2.45M Buy
28,729
+18,032
+169% +$1.48M 0.01% 1710
2018
Q1
$828K Sell
10,697
-36,177
-77% -$2.91M ﹤0.01% 2905
2017
Q4
$3.96M Buy
46,874
+20,974
+81% +$1.78M 0.01% 1022
2017
Q3
$2.21M Buy
25,900
+1,109
+4% +$91K 0.01% 1499
2017
Q2
$2.04M Buy
24,791
+13,886
+127% +$1.13M 0.01% 1475
2017
Q1
$917K Sell
10,905
-111,476
-91% -$8.93M ﹤0.01% 2155
2016
Q4
$9M Buy
122,381
+87,831
+254% +$6.54M 0.04% 399
2016
Q3
$2.77M Buy
34,550
+26,421
+325% +$2.11M 0.01% 936
2016
Q2
$640K Sell
8,129
-5,683
-41% -$428K ﹤0.01% 2496
2016
Q1
$995K Buy
+13,812
New +$1.05M 0.01% 1854
2015
Q4
Sell
-12,400
Closed -$1.03M 4256
2015
Q3
$1.04M Sell
12,400
-9,884
-44% -$834K 0.01% 1598
2015
Q2
$1.86M Buy
22,284
+19,350
+660% +$1.47M 0.01% 1052
2015
Q1
$213K Sell
2,934
-1,108
-27% -$78.9K ﹤0.01% 2836
2014
Q4
$279K Sell
4,042
-1,558
-28% -$105K ﹤0.01% 1940
2014
Q3
$363K Buy
+5,600
New +$355K ﹤0.01% 1721
2014
Q2
Sell
-70,686
Closed -$4.16M 2883
2014
Q1
$4.16M Buy
70,686
+64,085
+971% +$3.58M 0.05% 291
2013
Q4
$337K Buy
+6,601
New +$331K ﹤0.01% 1551
2013
Q3
Sell
-15,581
Closed -$765K 2943
2013
Q2
$765K Buy
+15,581
New +$848K 0.01% 1097

Other funds holding LLY

Jane Street's LLY Position: Q1 2026 in Review

Jane Street reduced its Eli Lilly (LLY) stake by 55% in Q1 2026, selling an estimated $141M and leaving 115,863 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #613.

Jane Street first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $488M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jane Street held 115,863 shares of Eli Lilly worth $107M as of Q1 2026.
  • Jane Street sold 139,261 Eli Lilly shares in Q1 2026, an estimated $141M.
  • Eli Lilly made up 0.01% of Jane Street's portfolio in Q1 2026, its #613 holding.
  • Jane Street first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Jane Street's Eli Lilly position peaked at $488M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.